The Center for Cancer Research (CCR) FLEX Program is an intramural funding mechanism. The objective is to facilitate the ability of CCR PIs to pursue high-risk, high-impact projects outside of a laboratory’s base allocations.
The FLEX program seeks to promote all areas of cancer research. Proposals can cover any aspect of the CCR research portfolio (basic, translational and/or clinical), but should clearly define how the proposed work will generate groundbreaking advances of relevance to cancer research. This also applies to COVID-19 related projects, which must demonstrate they directly add to our understanding of cancer biology or the development of treatments for cancer patients.
Get more details about this program